Study finds type 2 diabetes risk with growth hormone therapy

05/15/2011 | Reuters

Children who received growth hormone treatments had a more than eightfold increased risk of developing type 2 diabetes compared with a group of children in the general population, a study in the Journal of Clinical Endocrinology found. Growth hormone can interfere with insulin activity, but the study did not prove the therapy was responsible for the increased diabetes risk and further study is needed, the researchers said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX